A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Warm Autoimmune Hemolytic Anemia (wAIHA)

In brief

The purpose of this study is to evaluate efficacy and safety of ianalumab compared to placebo in patients with warm autoimmune hemolytic anemia, who failed at least one line of treatment.

Key facts

Study ID

NCT05648968

Run by

Novartis Pharmaceuticals

People needed

90

Starts

2022-12-30

Expected to finish

2028-12-19

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Minnesota Med Center — Minneapolis, Minnesota, United States
• Fred Hutchinson Cancer Center — Seattle, Washington, United States
• Novartis Investigative Site — CABA, Buenos Aires, Argentina
• Novartis Investigative Site — Buenos Aires, Argentina
• Novartis Investigative Site — Caba, Argentina
• Novartis Investigative Site — Garran, Australian Capital Territory, Australia
• Novartis Investigative Site — Melbourne, Victoria, Australia
• Novartis Investigative Site — Guangzhou, Guangdong, China
• Novartis Investigative Site — Hangzhou, Zhejiang, China
• Novartis Investigative Site — Dalian, China
• Novartis Investigative Site — Tianjin, China
• Novartis Investigative Site — Tianjin, China
• Novartis Investigative Site — Créteil, France
• Novartis Investigative Site — Lille, France
• Novartis Investigative Site — Nantes, France
• Novartis Investigative Site — Nice, France
• Novartis Investigative Site — Dresden, Germany
• Novartis Investigative Site — Essen, Germany
• Novartis Investigative Site — Giessen, Germany
• Novartis Investigative Site — Hanover, Germany
• Novartis Investigative Site — Debrecen, Hajdu Bihar Megye, Hungary
• Novartis Investigative Site — New Delhi, National Capital Territory of Delhi, India
• Novartis Investigative Site — Madurai, Tamil Nadu, India
• Novartis Investigative Site — Hyderabad, Telangana, India
• Michigan Center of Medical Research — Farmington Hills, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.